Skip to main content

Advertisement

SpringerLink
Log in

Interactions between Helicobacter pylori and gastroesophageal reflux disease

  • Review Article
  • Published:
Esophagus Aims and scope Submit manuscript

Abstract

Interactions between Helicobacter Pylori (HP) and gastroesophageal reflux disease (GERD) are a complex issue. Several pathophysiological factors influence the development and the course of GERD, HP infection might be only one of these. Many studies emphasize the co-existence of these diseases. HP infection could contribute to GERD through both a protective and an aggressive role. Gastric acid secretion is a key factor in the pathophysiology of reflux esophagitis. Depending on the type of gastritis related to HP, acid secretion may either increase or decrease. Gastritis in corpus leads to hypoacidity, while antrum gastritis leads to hyperacidity. In cases of antral gastritis and duodenal ulcers which have hyperacidity, the expectation is an improvement in pre-existing reflux esophagitis after eradication of HP. In adults, HP infection is often associated with atrophic gastritis in the corpus. Atrophic gastritis may protect against GERD. Pangastritis which leads to gastric atrophy is commonly associated with CagA strains of HP and it causes more severe gastric inflammation. In case of HP-positive corpus gastritis in the stomach, pangastritis, and atrophic gastritis, reflux esophagitis occurs frequently after eradication of HP. Nonetheless, as a predisposing disease of gastric cancer, HP should be treated. In conclusion, as the determinative factors affecting GERD involving in HP, detailed data on the location of gastric inflammation and CagA positivity should be obtained by the studies at future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ghoshal UC, Chourasia D. Gastroesophageal reflux disease and Helicobacter pylori: what may be the relationship? J Neurogastroenterol Motil. 2010;16:243–50.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Labenz J, Blum AL. Curing Hp infection in patients with duodenal ulcer may provoke reflux oesophagitis. Gastroenterology. 1997;112:1442–7.

    Article  CAS  PubMed  Google Scholar 

  3. Schwizer W, Fox M. Helicobacter pylori and gastroesophageal reflux disease: a complex organism in a complex host. J Pediatr Gastroenterol Nutr. 2004;38:12–5.

    Article  PubMed  Google Scholar 

  4. Manes G, Esposito P, Lioniello M, et al. Manometric and pH metric features in gastroesophageal reflux disease patients with and without Helicobacter pylori infection. Dig Liver Dis. 2000;32:372–7.

    Article  CAS  PubMed  Google Scholar 

  5. Koike T, Ohara S, Sekine H, Iijima K, Abe Y, Kato K, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut. 2001;49:330–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. El Serag HB, Sonnenberg A, Jamal MM, et al. Corpus gastritis is protective against reflux esophagitis. Gut. 1999;45:181–5.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Grande M, Cadeddu F, Villa M, Attina GM, Muzi MG, Nigro C, et al. Helicobacter pylori and gastroesophageal reflux disease. World J Surg Oncol. 2008;6:74.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol. 1999;94:3268–72.

    Article  Google Scholar 

  9. Fallone CA, Barkun AN, Friedman G, et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol. 2000;95:914–20.

    Article  CAS  PubMed  Google Scholar 

  10. Wu JCY, Chan FKL, Wong SK, et al. Effect of H pylori eradication on esophageal acid exposure in patients with reflux esophagitis. Aliment Pharmacol Therap. 2002;16:545–52.

    Article  CAS  Google Scholar 

  11. Sugimoto M, Uotani T, Ichikawa H, Andoh A, Furuta T. Gastroesophageal reflux disease in time covering eradication for all patients infected with Helicobacter pylori in Japan. Digestion. 2016;93:24–31.

    Article  CAS  PubMed  Google Scholar 

  12. Lupu VV, Ignat A, Ciubotariu G, Ciubară A, Moscalu M, Burlea M. Helicobacter pylori infection and gastroesophageal reflux in children. Dis Esophagus. 2016;29:1007–12.

    Article  CAS  PubMed  Google Scholar 

  13. Zentiline P, Iritano E, Vignale C, et al. Helicobacter pylori infection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2003;17:1057–64.

    Article  Google Scholar 

  14. Sharma P, Vakil N. Helicobacter pylori and reflux disease. Aliment Pharmacol Ther. 2003;17:287–305.

    Article  Google Scholar 

  15. Moon A, Solomon A, Beneck D, Cunningham-Rundles S. Positive association between Helicobacter pylori and gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr. 2009;49:283–8.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hackelsberger A, Gunther T, Schultze V, et al. Role of aging in the expression of Helicobacter pylori gastritis in the antrum, corpus, and cardia. Scand J Gastroenterol. 1999;34:138–43.

    Article  CAS  PubMed  Google Scholar 

  17. Xinias I, Maris T, Mavroudi A, Panteliadis C, Vandenplas Y. Helicobacter pylori infection has no impact on manometric and pH-metric findings in adolescents and young adults with gastroesophageal reflux and antral gastritis: eradication results to no significant clinical improvement. Pediatr Rep. 2013;5:e3.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Daugule I, Rowland M. Helicobacter pylori infection in children. Helicobacter. 2008;13(Suppl 1):41–6.

    Article  CAS  PubMed  Google Scholar 

  19. Graham DY, Yamaoka YH. H. Pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter. 1998;3:145–51.

    Article  CAS  PubMed  Google Scholar 

  20. Levine A, Milo T, Broide E, et al. Influence of Helicobacter pylori eradication on gastroesophageal reflux symptoms and epigastric pain in children and adolescents. Pediatrics. 2004;113:54–8.

    Article  PubMed  Google Scholar 

  21. Lipshutz W, Hughes W, Cohen S. The genesis of lower esophageal sphincter pressure: its identification through the use of gastrin antiserum. J Clin Invest. 1972;51:522–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Goyal RK, McGuigan JE. Is gastrin a major determinant of basal lower esophageal sphincter pressure? A double-blind controlled study using high titer gastrin antiserum. J Clin Invest. 1976;57:291–300.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Iijima K, Koike T, Shimosegawa T. Reflux esophagitis triggered after Helicobacter pylori eradication: a noteworthy demerit of eradication therapy among the Japanese? Front Microbiol. 2015;6:566.

    PubMed  PubMed Central  Google Scholar 

  24. Ishiki K, Mizuno M, Take S, et al. Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease. Clin Gastroenterol Hepatol. 2004;2:474–9.

    Article  PubMed  Google Scholar 

  25. Laine Loren, Sugg Jennifer. Effect of HP eradication on development of GERD symptoms: a post hoc analysis of eight double blind prospective studies. Am J Gastroenterol. 2002;97:2992–7.

    Article  PubMed  Google Scholar 

  26. Muramatsu A, Azuma T, Okajima T, et al. Evaluation of treatment for gastrooesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan. Aliment Pharmacol Ther. 2004;20(Suppl 1):102–6.

    Article  CAS  PubMed  Google Scholar 

  27. Vaira D, Vakil N, Rugge M, et al. Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects. Gut. 2003;52:1543–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Minatsuki C, Yamamichi N, Shimamoto T, Kakimoto H, Takahashi Y, Fujishiro M, et al. Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan. PLoS ONE. 2013;8(7):e69891.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lee YC, Chen TH, Chiu HM, Shun CT, Chiang H, Liu TY, Wu MS, Lin JT. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut. 2013;62:676–82.

    Article  PubMed  Google Scholar 

  30. Tan J, Wang Y, Sun X, Cui W, Ge J, Lin L. The effect of Helicobacter pylori eradication therapy on the development of gastroesophageal reflux disease. Am J Med Sci. 2015;349:364–71.

    Article  PubMed  Google Scholar 

  31. Wang XT, Zhang M, Chen CY, Lyu B. Helicobacter pylori eradication and gastroesophageal reflux disease: a Meta-analysis. Zhonghua Nei Ke Za Zhi. 2016;55:710–6 (Abstract).

    CAS  PubMed  Google Scholar 

  32. Hamada H, Haruma K, Mihara M, Kamada T, Yoshihara M, Sumii K, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther. 2000;14:729–35.

    Article  CAS  PubMed  Google Scholar 

  33. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet. 2006;367:2086–100.

    Article  PubMed  Google Scholar 

  34. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol. 2006;4:398–407.

    Article  PubMed  Google Scholar 

  35. Stadtlander CT, Waterbor JW. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis. 1999;20:2195–208.

    Article  CAS  PubMed  Google Scholar 

  36. Raghunath AS, Hungin AP, Wooff D, Childs S. Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis. Aliment Pharmacol Ther. 2004;20:733–44.

    Article  CAS  PubMed  Google Scholar 

  37. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol. 2007;5:1413–7.

    Article  PubMed  Google Scholar 

  38. Wang C, Yuan Y, Hunt RH. Helicobacter pylori infection and Barrett’s esophagus: a systematic review and meta-analysis. Am J Gastroenterol. 2009;104:492–500.

    Article  PubMed  Google Scholar 

  39. Fischbach LA, Nordenstedt H, Kramer JR, Gandhi S, Dick-Onuoha S, Lewis A, et al. The association between Barrett’s esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter. 2012;17:163–75.

    Article  PubMed  PubMed Central  Google Scholar 

  40. McColl KE. Review article: Helicobacter pylori and gastro-oesophageal reflux disease—the European perspective. Aliment Pharmacol Ther. 2004;20(Suppl. 8):36–9.

    Article  PubMed  Google Scholar 

  41. Xie T, Cui X, Zheng H, Chen D, He L, Jiang B. Metaanalysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease. Eur J Gastroenterol Hepatol. 2013;25:1195–205.

    CAS  PubMed  Google Scholar 

  42. Jung HK. Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil. 2011;17:14–27.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Gold BD. Helicobacter pylori infection in children. Curr Probl Pediatr Adolesc Health Care. 2001;31:247–66.

    Article  CAS  PubMed  Google Scholar 

  45. Shavalipour A, Malekpour H, Dabiri H, Kazemian H, Zojaji H, Bahroudi M. Prevalence of cytotoxin-associated genes of Helicobacter pylori among Iranian GERD patients. Gastroenterol Hepatol Bed Bench. 2017;10:178–83.

    PubMed  PubMed Central  Google Scholar 

  46. Hong SJ, Kim SW. Helicobacter pylori infection in gastroesophageal reflux disease in the Asian countries. Gastroenterol Res Pract. 2015;2015:985249.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Park JJ, Kim JW, Kim HJ, et al. The prevalence of and risk factors for Barrett’s esophagus in a Korean population: a nationwide multicenter prospective study. J Clin Gastroenterol. 2009;43:907–14.

    Article  PubMed  Google Scholar 

  48. Peng S, Cui Y, Xiao YL, et al. Prevalence of erosive esophagitis and Barrett’s esophagus in the adult Chinese population. Endoscopy. 2009;41:1011–7.

    Article  CAS  PubMed  Google Scholar 

  49. Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44:518–34.

    Article  Google Scholar 

  50. Miyamoto M, Haruma K, Kuwabara M, Nagano M, Okamoto T, Tanaka M. High incidence of newly-developed gastroesophageal reflux disease in the Japanese community: a 6-year follow-up study. J Gastroenterol Hepatol. 2008;23:393–7.

    Article  Google Scholar 

  51. Sharma P, Wani S, Romero Y, Johnson D, Hamilton F. Racial and geographic issues in gastroesophageal reflux disease. Am J Gastroenterol. 2008;103:2669–80.

    Article  PubMed  Google Scholar 

  52. Boeckxstaens G, El-Serag HB, Smout AJPM, Kahrilas PJ. Republished: symptomatic reflux disease: the present, the past and the future. Postgrad Med J. 2015;91:46–54.

    Article  PubMed  Google Scholar 

  53. Sherman P, Czinn S, Drumm B, Gottrand F, Kawakami E, Madrazo A, Oderda G, Seo JK, Sullivan P, Toyoda S, Weaver L, Wu TC. Helicobacter pylori infection in children and adolescents: working group report of the first world congress of pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2002;35(Suppl 2):S128–33.

    Article  PubMed  Google Scholar 

  54. Blecker U. Helicobacter pylori-associated gastroduodenal disease in childhood. South Med J. 1997;90:570–6.

    Article  CAS  PubMed  Google Scholar 

  55. Israel DM, Hassall E. Treatment and long-term follow-up of Helicobacter pylori-associated duodenal ulcer disease in children. J Pediatr. 1993;123:53–8.

    Article  CAS  PubMed  Google Scholar 

  56. Peterson WL, Graham DY, Marshall B, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol. 1993;88:1860–4.

    CAS  PubMed  Google Scholar 

  57. Hoepler W, Hammer K, Hammer J. Gastric phenotype in children with Helicobacter pylori infection undergoing upper endoscopy. Scand J Gastroenterol. 2011;46:293–8.

    Article  PubMed  Google Scholar 

  58. Langner C, Schneider NI, Plieschnegger W, Schmack B, Bordel H, Höfler B, Eherer AJ, Wolf EM, Rehak P, Vieth M. Cardiac mucosa at the gastro-oesophageal junction: indicator of gastro-oesophageal reflux disease? Data from a prospective central European multicentre study on histological and endoscopic diagnosis of oesophagitis (histoGERD trial). Histopathology. 2014;65:81–9.

    Article  PubMed  Google Scholar 

  59. Guiraldes E, Peña A, Duarte I, Triviño X, Schultz M, Larraín F, Espinosa MN, Harris P. Nature and extent of gastric lesions in symptomatic Chilean children with Helicobacter pylori associated gastritis. Acta Paediatr. 2002;91:39–44.

    Article  CAS  PubMed  Google Scholar 

  60. Carvalho MA, Machado NC, Ortolan EV, Rodrigues MA. Upper gastrointestinal histopathological findings in children and adolescents with nonulcer dyspepsia with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2012;55:523–9.

    Article  PubMed  Google Scholar 

  61. Kato S, Nishino Y, Ozawa K, Konno M, Maisawa S, Toyoda S, Tajiri H, Ida S, Fujisawa T, Iinuma K. The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease. J Gastroenterol. 2004;39:734–8.

    Article  PubMed  Google Scholar 

  62. Macarthur C, Saunders N, Feldman W. Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children. JAMA. 1995;273:729–34.

    Article  CAS  PubMed  Google Scholar 

  63. Bedoya A, Garay J, Sanzón F, Bravo LE, Bravo JC, Correa H, Craver R, Fontham E, Du JX, Correa P. Histopathology of gastritis in Helicobacter pylori-infected children from populations at high and low gastric cancer risk. Hum Pathol. 2003;34:206–13.

    Article  PubMed  Google Scholar 

  64. Mungan Z, Pınarbaşı Şimşek B. Gastroesophageal reflux disease and the relationship with Helicobacter pylori. Turk J Gastroenterol. 2017;28(Suppl 1):S61–7.

    Article  PubMed  Google Scholar 

  65. Pollet S, Gottrand F, Vincent P, et al. Gastroesophageal reflux disease and Helicobacter pylori infection in neurologically impaired children: inter-relations and therapeutic implications. J Pediatr Gastroenterol Nutr. 2004;38:70–4.

    Article  PubMed  Google Scholar 

  66. Kalach N, Bontems P, Koletzko S, Mourad-Baars P, Shcherbakov P, Celinska-Cedro D, Iwanczak B, Gottrand F, Martinez-Gomez MJ, Pehlivanoglu E, Oderda G, Urruzuno P, Casswall T, Lamireau T, Sykora J, Roma-Giannikou E, Veres G, Wewer V, Chong S, Charkaluk ML, Mégraud F, Cadranel S. Frequency and risk factors of gastric and duodenal ulcers or erosions in children: a prospective 1-month European multicenter study. Eur J Gastroenterol Hepatol. 2010;22:1174–81.

    Article  PubMed  Google Scholar 

  67. Oderda G, Shcherbakov P, Bontems P, Urruzuno P, Romano C, Gottrand F, Gómez MJ, Ravelli A, Gandullia P, Roma E, Cadranel S, De Giacomo C, Canani RB, Rutigliano V, Pehlivanoglu E, Kalach N, Roggero P, Celinska-Cedro D, Drumm B, Casswall T, Ashorn M, Arvanitakis SN. Results from the pediatric European register for treatment of Helicobacter pylori (PERTH). Helicobacter. 2007;12:150–6.

    Article  PubMed  Google Scholar 

  68. Tam YH, Lee KH, To KF, Chan KW, Cheung ST. Helicobacter pylori-positive versus Helicobacter pylori-negative idiopathic peptic ulcers in children with their long-term outcomes. J Pediatr Gastroenterol Nutr. 2009;48:299–305.

    Article  PubMed  Google Scholar 

  69. Daugule I, Rumba I, Engstrand L, Ejderhamn J. Infection with cagA-Positive and cagA-Negative types of Helicobacter pylori among children and adolescents with gastrointestinal symptoms in Latvia. Eur J Clin Microbiol Infect Dis. 2003;22:622–4.

    CAS  PubMed  Google Scholar 

  70. Arents NL, Thijs JC, van Zwet AA, Kleibeuker JH. Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period. Eur J Gastroenterol Hepatol. 2004;16:779–83.

    Article  PubMed  Google Scholar 

  71. Kato S, Kikuchi S, Nakajima S. When does gastric atrophy develop in Japanese children? Helicobacter. 2008;13:278–81.

    Article  Google Scholar 

  72. Kekki M, Samloff IM, Varis K, Ihamäki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol Suppl. 1991;186:109–16.

    Article  CAS  PubMed  Google Scholar 

  73. Waldum HL, Sagatun L, Mjønes P. Gastrin and gastric cancer. Front Endocrinol (Lausanne). 2017;8:1.

    Article  Google Scholar 

  74. Dimitrov G, Gottrand F. Does gastric atrophy exist in children? World J Gastroenterol. 2006;12:6274–9.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Whitney AE, Guarner J, Hutwagner L, Gold BD. Helicobacter pylori gastritis in children and adults: comparative histopathologic study. Ann Diagn Pathol. 2000;4:279–85.

    Article  CAS  PubMed  Google Scholar 

  76. Usta Y, Saltk-Temizel IN, Ozen H. Gastric atrophy and intestinal metaplasia in Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2004;38:548.

    Article  PubMed  Google Scholar 

  77. Oztürk Y, Büyükgebiz B, Arslan N, Ozer E. Antral glandular atrophy and intestinal metaplasia in children with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2003;37:96–7.

    Article  PubMed  Google Scholar 

  78. Guarner J, Bartlett J, Whistler T, Pierce-Smith D, Owens M, Kreh R, Czinn S, Gold BD. Can pre-neoplastic lesions be detected in gastric biopsies of children with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2003;37:309–14.

    Article  PubMed  Google Scholar 

  79. Boukthir S, Mrad SM, Kalach N, Sammoud A. Gastric atrophy and Helicobacter pylori infection in children. Trop Gastroenterol. 2009;30:107–9.

    CAS  PubMed  Google Scholar 

  80. Pacifico L, Anania C, Osborn JF, Ferraro F, Chiesa C. Consequences of Helicobacter pylori infection in children. World J Gastroenterol. 2010;16:5181–94.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Matsuhisa T, Aftab H. Observation of gastric mucosa in Bangladesh, the country with the lowest incidence of gastric cancer, and Japan, the country with the highest incidence. Helicobacter. 2012;17:396–401.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, et al. Helicobacter pylori Infection and the Risk of Barrett’s Oesophagus: a Community-Based Study. Gut. 2008;57:727–33.

    Article  CAS  PubMed  Google Scholar 

  83. Inomata Y, Koike T, Ohara S, Abe Y, Sekine H, Iijima K, et al. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status. Am J Gastroenterol. 2006;101:926–33.

    Article  PubMed  Google Scholar 

  84. Ricuarte O, Gutierrez O, Cardona H, Kim JG, Graham DY, El-Zimaity HM. Atrophic gastritis in young children and adolescents. J Clin Pathol. 2005;58:1189–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Riddell RH. Pathobiology of Helicobacter pylori infection in children. Can J Gastroenterol. 1999;13:599–603.

    Article  CAS  PubMed  Google Scholar 

  86. Ghoshal UC, Tiwari S, Dhingra S, et al. Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma. Dig Dis Sci. 2008;53:1215–22.

    Article  PubMed  Google Scholar 

  87. Sayehmiri F, Kiani F, Sayehmiri K, Soroush S, Asadollahi K, Alikhani MY, Delpisheh A, Emaneini M, Bogdanović L, Varzi AM, Zarrilli R, Taherikalani M. Prevalence of cagA and vacA among Helicobacter pylori-infected patients in Iran: a systematic review and meta-analysis. J Infect Dev Ctries. 2015;9:686–96.

    Article  CAS  PubMed  Google Scholar 

  88. Nawfal RH, Mohammadi M, Talebkhan Y, Doraghi MP, Letley DK, Muhammad M, Argent HR, Atherton CJ. Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori- associated disease. J Clin Microbiol. 2008;46:1774–9.

    Article  CAS  Google Scholar 

  89. Saribasak H, Salih BA, Yamaoka Y, Sander E. Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J Clin Microbiol. 2004;42:1648–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Chiba H, Gunji T, Sato H, Iijima K, Fujibayashi K, Okumura M, et al. A cross-sectional study on the risk factors for erosive esophagitis in young adults. Intern Med. 2012;51:1293–9.

    Article  PubMed  Google Scholar 

  91. Azuma T, Yamazaki S, Yamakawa A, Ohtani M, Muramatsu A, Suto H, et al. Association between diversity in the Src homology 2 domain—containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis. 2004;189:820–7.

    Article  CAS  PubMed  Google Scholar 

  92. Luzza F, Pensabene L, Imeneo M, Mancuso M, Giancotti L, La Vecchia AM, Costa MC, Strisciuglio P, Pallone F. Antral nodularity and positive CagA serology are distinct and relevant markers of severe gastric inflammation in children with Helicobacterpylori infection. Helicobacter. 2002;7(1):46–52.

    Article  PubMed  Google Scholar 

  93. Vorobjova T, Grünberg H, Oona M, Maaroos HI, Nilsson I, Wadström T, Covacci A, Uibo R. Seropositivity to Helicobacter pylori and CagA protein in schoolchildren of different ages living in urban and rural areas in southern Estonia. Eur J Gastroenterol Hepatol. 2000;12:97–101.

    Article  CAS  PubMed  Google Scholar 

  94. Sokucu S, Ozden AT, Suoglu OD, Elkabes B, Demir F, Cevikbas U, et al. CagA positivity and its association with gastroduodenal disease in Turkish children undergoing endoscopic investigation. J Gastroenterol. 2006;41:533–9.

    Article  CAS  PubMed  Google Scholar 

  95. Mourad-Baars P, Hussey S, Jones NL. Helicobacter pylori infection and childhood. Helicobacter. 2010;15:53–9.

    Article  PubMed  Google Scholar 

  96. Kütükçüler N, Aydogdu S, Göksen D, Caglayan S, Yagcyi RV. Increased mucosal inflammatory cytokines in children with Helicobacter pylori-associated gastritis. Acta Paediatr. 1997;86:928–31.

    Article  PubMed  Google Scholar 

  97. Bytzer P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al. European helicobacter study group. Management of Helicobacter pylori infection–the Maastricht IV/Florence consensus report. Gut. 2012;61:646–64.

    Article  Google Scholar 

  98. Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, et al. Japanese Society for Helicobacter Research. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010;15:1–20.

    Article  CAS  PubMed  Google Scholar 

  99. Kawanishi M. Development of reflux esophagitis following Helicobacter pylori eradication. J Gastroenterol. 2005;40:1024–8.

  100. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida To, Yokota K, et al. Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: prospective endoscopic evaluation. J Gastroenterol Hepatol. 2009;24:107–13.

  101. Inoue H, Imoto I, Taguchi Y, Kuroda M, Nakamura M, Horiki N, et al. Reflux esophagitis after eradication of Helicobacter pylori is associated with the degree of hiatal hernia. Scand J Gastroenterol. 2004;39:1061–5.

  102. Nam SY, Choi IJ, Ryu KH, Kim BC, Kim CG, Nam BH. Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am J Gastroenterol. 2010;105:2153–62.

  103. Kim N, Lim SH, Lee KH. No protective role of Helicobacter pylori in the pathogenesis of reflux esophagitis in patients with duodenal or benign gastric ulcer in Korea. Dig Dis Sci. 2001;46:2724–32.

  104. Kim N, Lee SW, Kim JI, Baik GH, Kim SJ, Seo GS, et al. Effect of Helicobacter pylori eradication on the development of reflux esophagitis and gastroesophageal reflux symptoms: a nationwide multi-center prospective study. Gut Liver. 2011;5:437–46.

  105. Wu JC, Chan FK, Ching JY, Leung WK, Hui Y, Leong R, et al. Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial. Gut. 2004;53:174–9.

  106. Vakil N, Talley NJ, Stolte M, Sundin M, Junghard O, Bolling-Sternevald O. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2006;24:55–63.

  107. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon ATR, Bazzoli F, et al. Management of Helicobacter pylori infection – the Maastricht IV/Florence Consensus Report. Gut. 2012;61:646–64.

  108. Bytzer P, Aalykke C, Rune S, Weywadt L, Gjorup T, Eriksen J, et al. Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group. Scand J Gastroenterol. 2000;35:1023–32.

  109. Harvey RF, Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project. BMJ. 2004;328:1417.

  110. Ott EA, Mazzoleni LE, Edelweiss MI, Sander GB, Wortmann AC, Theil AL, et al. Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial. Aliment Pharmacol Ther. 2005;21:1231–9.

  111. Befrits R, Sjostedt S, Odman B, Sorngard H, Lindberg G. Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease. Helicobacter. 2000;5:202–5.

  112. Moayyedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon AT. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology. 2001;121:1120–6.

  113. Saad AM, Choudhary A, Bechtold ML. Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2012;47:129–35.

  114. Cremonini F, Di Caro S, Delgado-Aros S, Sepulveda A, Gasbarrini G, Gasbarrini A, Camilleri M. Meta analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2003;18:279–89.

  115. Yaghoobi M, Farrokhyar F, Yuan Y, Hunt RH. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol. 2010;105:1007–13.

Download references

Funding

None.

Author information

Author notes

    Authors and Affiliations

    1. Pediatric Department, Baskent University, Istanbul Education and Research Hospital, Cemil Topuzlu Cad. Yuvam Apt. N0:32/12 Ciftehavuzlar, Kadıkoy, 34726, Istanbul, Turkey

      Oya Yucel

    Authors
    1. Oya Yucel
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Oya Yucel.

    Ethics declarations

    Ethical Statement

    This article does not contain any studies with human or animal subjects performed by any author.

    Conflict of interest

    The author declares no conflict of interest.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Yucel, O. Interactions between Helicobacter pylori and gastroesophageal reflux disease. Esophagus 16, 52–62 (2019). https://doi.org/10.1007/s10388-018-0637-5

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s10388-018-0637-5

    Keywords

    Search

    Navigation